Cargando…
Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
BACKGROUND: Cells within breast cancer stem cell populations have been confirmed to have a CD44(+)CD24(−) phenotype. Strong expression of CD44 plays a critical role in numerous types of human cancers. CD44 is involved in cell differentiation, adhesion, and metastasis of cancer cells. METHODS: In thi...
Autores principales: | Van Phuc, Pham, Nhan, Phan Lu Chinh, Nhung, Truong Hai, Tam, Nguyen Thanh, Hoang, Nguyen Minh, Tue, Vuong Gia, Thuy, Duong Thanh, Ngoc, Phan Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143907/ https://www.ncbi.nlm.nih.gov/pubmed/21792314 http://dx.doi.org/10.2147/OTT.S21431 |
Ejemplares similares
-
Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment
por: Van Pham, Phuc, et al.
Publicado: (2012) -
Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
por: Pham, Phuc V, et al.
Publicado: (2011) -
The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
por: Tran, Vinh Thanh, et al.
Publicado: (2020) -
The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003) -
CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)